Nakano T - Search Results

1

Mitochondrial surface coating with artificial lipid membrane improves the transfer efficacy.

Nakano T, Nakamura Y, Park JH, Tanaka M, Hayakawa K. Nakano T, et al. Commun Biol. 2022 Jul 25;5(1):745. doi: 10.1038/s42003-022-03719-9. Commun Biol. 2022. PMID: 35879398 Free PMC article.

2

Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism.

Hayakawa K, Irie K, Sano K, Watanabe T, Higuchi S, Enoki M, Nakano T, Harada K, Ishikane S, Ikeda T, Fujioka M, Orito K, Iwasaki K, Mishima K, Fujiwara M. Hayakawa K, et al. Among authors: nakano t. Biol Pharm Bull. 2009 Sep;32(9):1538-44. doi: 10.1248/bpb.32.1538. Biol Pharm Bull. 2009. PMID: 19721229 Free article.

3

ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

Fujioka M, Hayakawa K, Mishima K, Kunizawa A, Irie K, Higuchi S, Nakano T, Muroi C, Fukushima H, Sugimoto M, Banno F, Kokame K, Miyata T, Fujiwara M, Okuchi K, Nishio K. Fujioka M, et al. Among authors: nakano t. Blood. 2010 Feb 25;115(8):1650-3. doi: 10.1182/blood-2009-06-230110. Epub 2009 Nov 13. Blood. 2010. PMID: 19965676 Free article.

4

Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice.

Hayakawa K, Nakano T, Irie K, Higuchi S, Fujioka M, Orito K, Iwasaki K, Jin G, Lo EH, Mishima K, Fujiwara M. Hayakawa K, et al. Among authors: nakano t. J Cereb Blood Flow Metab. 2010 Apr;30(4):871-82. doi: 10.1038/jcbfm.2009.257. Epub 2009 Dec 9. J Cereb Blood Flow Metab. 2010. PMID: 19997116 Free PMC article.

5

ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.

Fujioka M, Nakano T, Hayakawa K, Irie K, Akitake Y, Sakamoto Y, Mishima K, Muroi C, Yonekawa Y, Banno F, Kokame K, Miyata T, Nishio K, Okuchi K, Iwasaki K, Fujiwara M, Siesjö BK. Fujioka M, et al. Among authors: nakano t. Neurol Sci. 2012 Oct;33(5):1107-15. doi: 10.1007/s10072-011-0913-9. Epub 2012 Jan 3. Neurol Sci. 2012. PMID: 22212812 Free article.

6

[Necessity of personalized initial loading dose calculation of teicoplanin by clinical pharmacist-examination of the utility of using systemic inflammatory response syndrome score-].

Nakano T, Nakamura Y, Togawa A, Takata T, Ishikura H, Mishima K, Futagami K. Nakano T, et al. Yakugaku Zasshi. 2014;134(12):1367-73. doi: 10.1248/yakushi.14-00185. Yakugaku Zasshi. 2014. PMID: 25452245 Free article. Japanese.

7

Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.

Nakano T, Irie K, Hayakawa K, Sano K, Nakamura Y, Tanaka M, Yamashita Y, Satho T, Fujioka M, Muroi C, Matsuo K, Ishikura H, Futagami K, Mishima K. Nakano T, et al. Brain Res. 2015 Oct 22;1624:330-335. doi: 10.1016/j.brainres.2015.07.027. Epub 2015 Aug 5. Brain Res. 2015. PMID: 26254727

8

Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus.

Nakamura Y, Uchiyama M, Hara S, Mizunuma M, Nakano T, Ishikura H, Hoshino K, Kawano Y, Takata T. Nakamura Y, et al. Among authors: nakano t. Infect Dis Ther. 2016 Mar;5(1):81-7. doi: 10.1007/s40121-015-0100-z. Epub 2015 Dec 19. Infect Dis Ther. 2016. PMID: 26686501 Free PMC article.

9

Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.

Nakamura Y, Nakano T, Irie K, Sano K, Tanaka J, Yamashita Y, Satho T, Matsuo K, Fujioka M, Ishikura H, Mishima K. Nakamura Y, et al. Among authors: nakano t. J Neurol Sci. 2016 Mar 15;362:278-82. doi: 10.1016/j.jns.2016.01.047. Epub 2016 Jan 22. J Neurol Sci. 2016. PMID: 26944163

10

Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.

Nakano T, Nakamura Y, Takata T, Irie K, Sano K, Imakyure O, Mishima K, Futagami K. Nakano T, et al. Int J Clin Pharm. 2016 Aug;38(4):908-14. doi: 10.1007/s11096-016-0308-3. Epub 2016 Apr 28. Int J Clin Pharm. 2016. PMID: 27125378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,467 results

Search Page